Also known as آسٹیوپوروسس مینجمنٹ
Diabetologist
M.B.B.S, M.R.C.P, PG Dip.Diabetes (UK), MD-Diabetes & Endocrine
Diabetologist
M.B.B.S, M.R.C.P, PG Dip.Diabetes (UK), MD-Diabetes & Endocrine
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Pulmonologist
FACCP, MBBS, Diplomate American Board of Internal Medicine, Diplomat American Board of Pulmonary Medicine, Diplomat American Board of Critical Care Medicine, Diplomat American Board of Sleep Medicine
Pulmonologist
FACCP, MBBS, Diplomate American Board of Internal Medicine, Diplomat American Board of Pulmonary Medicine, Diplomat American Board of Critical Care Medicine, Diplomat American Board of Sleep Medicine
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, FCPS
Gastroenterologist
MBBS, FRCP, MRCP, CCST
Endocrinologist
M.B.B.S., F.C.P.S. (Medicine), F.C.P.S.(Endocrinology), M.R.C.P (UK), MRCPE (UK)
Endocrinologist
M.B.B.S., F.C.P.S. (Medicine), F.C.P.S.(Endocrinology), M.R.C.P (UK), MRCPE (UK)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures